Clinical Trials
3 trialsNCT05815186 2024-03-29
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
NYU Langone Health
Phase 2 Withdrawn
NCT05400577 2023-07-17
Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC
Fox Chase Cancer Center
Phase 2 Withdrawn
NCT05251038 2023-05-11
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer
Hoosier Cancer Research Network
Phase 1/2 Withdrawn